PrimeRFP SCOUT · Federal Contract Recompete Brief

36E79726D0009Implementing EO 14398 DEI discrimination — Sanofi Vaccines Us Inc

Sanofi Vaccines Us Inc holds $3.7B across 396 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 5 related awards in the incumbent pipeline. Set-aside status: NONE.

Nac Pharmaceuticals (36E797)

Awarding office

Sanofi Vaccines Us Inc

Recipient

—

Estimated value

6505

PSC

NONE

Set-aside

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Sanofi Vaccines Us Inc — $90

Contract facts

NONE

Contract number36E79726D0009

Also listed as36E797-26-D-0009

AgencyNac Pharmaceuticals (36E797)

Awarding officeNac Pharmaceuticals (36E797)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentSanofi Vaccines Us Inc

UEINCXBGGQ8YTU9

PSC6505

Related solicitation36E79725R0064

IMPLEMENTING EO 14398 DEI DISCRIMINATION is a federal NONE award for Nac Pharmaceuticals (36E797) held by Sanofi Vaccines Us Inc. Estimated value —. Related solicitation 36E79725R0064.

Incumbent footprint

Public record

Sanofi Vaccines Us Inc — $3.7B obligated across 396 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($3.7B) · all agencies · Top 4 shown (98%); remaining ~2% is other agencies.

Department of Health and Human Services (HHS)$3.6B · 97%Department of Defense (DOD)$29.1M · 1%Department of Veterans Affairs (VA)$6.9M · 0%Department of State (DOS)$2.4M · 0%

Related awards

Same incumbent

SPE2DP26F2910

8511928943!INFLUENZA VIRUS VAC

$3.0M

Sep 25, 2026

SPE2DP26F2847

8511923395!INFLUENZA VIRUS VAC

$2.9M

Sep 25, 2026

SPE2DP26F2909

8511928883!INFLUENZA VIRUS VAC

$824K

Sep 25, 2026

15F06724F0000477

TRAVEL VACCINES.

$504K

Dec 31, 2026

15F06726F0000243

SANOFI TRAVEL VACCINES

$200K

Dec 31, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36E79726D0009?

36E79726D0009 (Implementing EO 14398 DEI discrimination) is a Nac Pharmaceuticals (36E797) award with an estimated value of —, currently held by Sanofi Vaccines Us Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36E797-26-D-0009?

36E797-26-D-0009 is the dashed form of PIID 36E79726D0009 (Implementing EO 14398 DEI discrimination), held by Sanofi Vaccines Us Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36E79726D0009?

Nac Pharmaceuticals (36E797) awarded 36E79726D0009 to Sanofi Vaccines Us Inc.

Who is the incumbent on 36E79726D0009?

Sanofi Vaccines Us Inc is the incumbent with $3.7B across 396 related awards in SCOUT’s public footprint.

When does Sanofi Vaccines Us Inc’s 36E79726D0009 come up for recompete?

SCOUT tracks a period-of-performance end of an unstated date. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on 36E79726D0009 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 25, 2026 · refreshed monthly